1. KSF investigates NV5's sale to Acuren, scrutinizing adequacy of deal. 2. NV5 shareholders would receive $23.00 per share in the transaction. 3. Investigation may indicate potential undervaluation of NV5 by Acuren.
The proposed sale price to NV5 shareholders does not reflect immediate market changes. Similar past investigations have had minimal lasting effects on stock prices.
Investor concerns about the adequacy of the sale valuation could lead to short-term market indecision.
The investigation may create temporary uncertainty, affecting market sentiment but likely not long-term fundamentals.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)-- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NV5 Global, Inc. (NasdaqGS: NVEE) to Acuren Corporation (NYSE: TIC). Under the terms of the proposed transaction, NV5 shareholders will receive approximately $23.00 per share consisting of $10.00 in cash and an estimated $13.00 in shares of Acuren, subject to adjustment. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-nvee/ to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.